Literature DB >> 22199059

Ultraviolet-based therapy for vitiligo: what's new?

Iltefat H Hamzavi1, Henry W Lim, Zain U Syed.   

Abstract

Vitiligo is an ancient disease in which depigmented and hypopigmented macules appear on the skin. It is a disfiguring condition that may lead to severe psychological trauma. Among the many treatment modalities available for use in vitiligo, those using light therapy, and in particular ultraviolet (UV) light, are some of the most effective treatments. UV-based therapy includes phototherapy (narrowband UVB), photochemotherapy (psoralens with UVA), and targeted phototherapy (excimer laser and excimer lamp). It is important for any practitioner of UV-based therapy to understand the efficacy of each treatment type, as well as their respective adverse effects. In order to take full advantage of UV-based therapy, location, dosing, and photoadaptation must also be taken into account. This review discusses the various UV-based therapeutic options, adjuvant therapies, optimal dosing guidelines, appropriate patient selection, future treatment options, and recommendations based upon the current evidence and the authors' experience with vitiligo.

Entities:  

Mesh:

Year:  2012        PMID: 22199059     DOI: 10.4103/0378-6323.90945

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  9 in total

1.  [Treatment of vitiligo].

Authors:  M Meurer; M Schild
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

2.  The Efficacy of a Gain-Switched 311-nm Titanium:Sapphire Laser in the Treatment of Vitiligo: A Pilot Study of 14 Patients.

Authors:  Jung Min Bae; Ji Hae Lee; Yu Seok Jung; Gyong Moon Kim
Journal:  JAMA Dermatol       Date:  2017-10-01       Impact factor: 10.282

3.  Utility of dermoscopy for evaluating the therapeutic efficacy of tacrolimus ointment plus 308-nm excimer laser combination therapy in localized vitiligo patients.

Authors:  Lu-Mei Wang; Wan-Jiao Lu; Jing-Tao Yuan; Bi-Bing Zeng; Dan Li; Feng Zhang; Jun-Jie Li
Journal:  Exp Ther Med       Date:  2018-02-28       Impact factor: 2.447

4.  Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy.

Authors:  Youssef Elbayoumy Youssef; Heba Elsayed Abdelmoneim Eldegla; Rana Samir Mahmoud Elmekkawy; Mohammad Ali Gaballah
Journal:  Arch Dermatol Res       Date:  2022-03-23       Impact factor: 3.017

5.  Non-invasive diffuse reflectance measurements of cutaneous melanin content can predict human sensitivity to ultraviolet radiation.

Authors:  Sergio G Coelho; Barbara Z Zmudzka; Lanlan Yin; Sharon A Miller; Yuji Yamaguchi; Taketsugu Tadokoro; Vincent J Hearing; Janusz Z Beer
Journal:  Exp Dermatol       Date:  2013-04       Impact factor: 3.960

6.  Narrow band-ultraviolet B versus clobetasol propionate foam in the treatment of vitiligo: a retrospective study.

Authors:  Giuseppe Stinco; Giusto Trevisan; Cinzia Buligan; Giorgia Gregoraci; Sergio De Marchi; Nicola di Meo; Pasquale Patrone
Journal:  Dermatol Ther (Heidelb)       Date:  2013-06-04

7.  A review of the use of tanning beds as a dermatological treatment.

Authors:  Kyle P Radack; Michael E Farhangian; Kathryn L Anderson; Steven R Feldman
Journal:  Dermatol Ther (Heidelb)       Date:  2015-03-04

8.  Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes.

Authors:  Jerry Wan; Fuquan Lin; Wei Zhang; Aie Xu; Joseph DeGiorgis; Hongguang Lu; Yinsheng Wan
Journal:  Int J Biol Sci       Date:  2017-02-25       Impact factor: 6.580

9.  Efficacy of targeted narrowband ultraviolet B therapy in vitiligo.

Authors:  Imran Majid
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.